Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CSTL
#2432
Castle Biosciences, Inc. - Common stock
34.2
6
USD
+0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.53%
Monthly Change
+43.17%
6 month change
+19.21%
Year Change
+39.18%
Previous Close
34.0
8
Open
34.2
6
Low
34.2
6
High
34.2
6
Volume
54
Markets
US Stock Market
Healthcare
Diagnostics & Research
CSTL
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Quarterly report, Q3 FY2024
2024.11.04
CASTLE BIOSCIENCES INC quarterly report, Q3 FY2024
10-Q
Current report, Q3 FY2024
2024.08.05
CASTLE BIOSCIENCES INC current report, Q3 FY2024
8-K
Quarterly report, Q2 FY2024
2024.08.05
CASTLE BIOSCIENCES INC quarterly report, Q2 FY2024
10-Q
1
2
3
News
Does Castle Biosciences (CSTL) Have the Potential to Rally 31.46% as Wall Street Analysts Expect?
Castle Biosciences, Inc. (CSTL) Q2 2026 Earnings Call Transcript
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates
Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises
OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook
EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises
JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations
BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised
Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus
AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales